Search Results - "Neil, Jason R."

Refine Results
  1. 1

    Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling by Spangler, Jamie B., Neil, Jason R., Abramovitch, Sivan, Yarden, Yosef, White, Forest M., Lauffenburger, Douglas A., Wittrup, K. Dane, Kuriyan, John

    “…Due to its common dysregulation in epithelial-based cancers and extensive characterization of its role in tumor growth, epidermal growth factor receptor (EGFR)…”
    Get full text
    Journal Article
  2. 2

    Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein by Neil, Jason R., Verma, Arvind, Kronewitter, Scott R., McGee, William M., Mullen, Christopher, Viirtola, Marjaana, Kotovuori, Annika, Friedrich, Herdis, Finell, Johan, Rannisto, Joni, Syka, John E. P., Stephenson, James L.

    Published in Scientific reports (15-09-2021)
    “…Treatment of antibiotic-resistant infections is dependent on the detection of specific bacterial genes or proteins in clinical assays. Identification of…”
    Get full text
    Journal Article
  3. 3

    Fibulins 3 and 5 antagonize tumor angiogenesis in vivo by ALBIG, Allan R, NEIL, Jason R, SCHIEMANN, William P

    Published in Cancer research (Chicago, Ill.) (01-03-2006)
    “…Lethal tumor growth and progression cannot occur without angiogenesis, which facilitates cancer cell proliferation, survival, and dissemination. Fibulins…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Transforming growth factor-β and the hallmarks of cancer by Tian, Maozhen, Neil, Jason R., Schiemann, William P.

    Published in Cellular signalling (01-06-2011)
    “…Tumorigenesis is in many respects a process of dysregulated cellular evolution that drives malignant cells to acquire six phenotypic hallmarks of cancer,…”
    Get full text
    Journal Article
  6. 6

    Epidermal growth factor receptor downregulation by small heterodimeric binding proteins by Hackel, Benjamin J., Neil, Jason R., White, Forest M., Wittrup, K.Dane

    Published in Protein engineering, design and selection (01-02-2012)
    “…No single engineered protein has been shown previously to robustly downregulate epidermal growth factor receptor (EGFR), a validated cancer target. A panel of…”
    Get full text
    Journal Article
  7. 7

    Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-β through a PGE2-dependent mechanisms by Neil, Jason R., Johnson, Kyle M., Nemenoff, Raphael A., Schiemann, William P.

    Published in Carcinogenesis (New York) (01-11-2008)
    “…Although it is well established that mammary tumorigenesis converts transforming growth factor-β (TGF-β) from a tumor suppressor to a tumor promoter, the…”
    Get full text
    Journal Article
  8. 8

    Altered TAB1:IκB Kinase Interaction Promotes Transforming Growth Factor β-Mediated Nuclear Factor-κB Activation during Breast Cancer Progression by NEIL, Jason R, SCHIEMANN, William P

    Published in Cancer research (Chicago, Ill.) (01-03-2008)
    “…The conversion of transforming growth factor β (TGF-β) from a tumor suppressor to a tumor promoter occurs frequently during mammary tumorigenesis, yet the…”
    Get full text
    Journal Article
  9. 9

    DrugMap: A quantitative pan-cancer analysis of cysteine ligandability by Takahashi, Mariko, Chong, Harrison B, Zhang, Siwen, Yang, Tzu-Yi, Lazarov, Matthew J, Harry, Stefan, Maynard, Michelle, Hilbert, Brendan, White, Ryan D, Murrey, Heather E, Tsou, Chih-Chiang, Vordermark, Kira, Assaad, Jonathan, Gohar, Magdy, Dürr, Benedikt R, Richter, Marianne, Patel, Himani, Kryukov, Gregory, Brooijmans, Natasja, Alghali, Aliyu Sidi Omar, Rubio, Karla, Villanueva, Antonio, Zhang, Junbing, Ge, Maolin, Makram, Farah, Griesshaber, Hanna, Harrison, Drew, Koglin, Ann-Sophie, Ojeda, Samuel, Karakyriakou, Barbara, Healy, Alexander, Popoola, George, Rachmin, Inbal, Khandelwal, Neha, Neil, Jason R, Tien, Pei-Chieh, Chen, Nicholas, Hosp, Tobias, van den Ouweland, Sanne, Hara, Toshiro, Bussema, Lillian, Dong, Rui, Shi, Lei, Rasmussen, Martin Q, Domingues, Ana Carolina, Lawless, Aleigha, Fang, Jacy, Yoda, Satoshi, Nguyen, Linh Phuong, Reeves, Sarah Marie, Wakefield, Farrah Nicole, Acker, Adam, Clark, Sarah Elizabeth, Dubash, Taronish, Kastanos, John, Oh, Eugene, Fisher, David E, Maheswaran, Shyamala, Haber, Daniel A, Boland, Genevieve M, Sade-Feldman, Moshe, Jenkins, Russell W, Hata, Aaron N, Bardeesy, Nabeel M, Suvà, Mario L, Martin, Brent R, Liau, Brian B, Ott, Christopher J, Rivera, Miguel N, Lawrence, Michael S, Bar-Peled, Liron

    Published in Cell (09-05-2024)
    “…Cysteine-focused chemical proteomic platforms have accelerated the clinical development of covalent inhibitors for a wide range of targets in cancer. However,…”
    Get more information
    Journal Article
  10. 10

    SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system by Schiemann, Barbara J, Neil, Jason R, Schiemann, William P

    Published in Molecular biology of the cell (01-10-2003)
    “…Secreted protein, acidic and rich in cysteine (SPARC) is a multifunctional secreted protein that regulates cell-cell and cell-matrix interactions, leading to…”
    Get full text
    Journal Article
  11. 11

    The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta by Sokol, Jonathan P, Neil, Jason R, Schiemann, Barbara J, Schiemann, William P

    Published in Breast cancer research : BCR (01-01-2005)
    “…Transforming growth factor-beta (TGF-beta) is a potent suppressor of mammary epithelial cell (MEC) proliferation and is thus an inhibitor of mammary tumor…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Direct detection of intact Klebsiella pneumoniae carbapenemase variants from cell lysates: Identification, characterization and clinical implications by McGee, William M., Faron, Matthew L., Neil, Jason R., Kronewitter, Scott R., Buchan, Blake W., Ledeboer, Nathan A., Stephenson, James L.

    “…•LC-MS methods are used to identify intact Klebsiella pneumoniae carbapenemase (KPC).•Mass spectrometry validates the mature form of KPC based on molecular…”
    Get full text
    Journal Article
  14. 14

    X-linked Inhibitor of Apoptosis Protein and Its E3 Ligase Activity Promote Transforming Growth Factor-Β-mediated Nuclear Factor-κB Activation during Breast Cancer Progression by Neil, Jason R., Tian, Maozhen, Schiemann, William P.

    Published in The Journal of biological chemistry (07-08-2009)
    “…The precise sequence of events that enable mammary tumorigenesis to convert transforming growth factor-Β (TGF-Β) from a tumor suppressor to a tumor promoter…”
    Get full text
    Journal Article
  15. 15

    Transforming growth factor-[beta] and the hallmarks of cancer by Tian, Maozhen, Neil, Jason R, Schiemann, William P

    Published in Cellular signalling (01-06-2011)
    “…Tumorigenesis is in many respects a process of dysregulated cellular evolution that drives malignant cells to acquire six phenotypic hallmarks of cancer,…”
    Get full text
    Journal Article
  16. 16

    Altered TAB1:IKK Interaction Promotes TGF-β-Mediated NF-κB Activation During Breast Cancer Progression by Neil, Jason R., Schiemann, William P.

    Published in Cancer research (Chicago, Ill.) (01-03-2008)
    “…The conversion of TGF-β from a tumor suppressor to a tumor promoter occurs frequently during mammary tumorigenesis, yet the molecular mechanisms underlying…”
    Get full text
    Journal Article
  17. 17

    X-linked Inhibitor of Apoptosis Protein and Its E3 Ligase Activity Promote Transforming Growth Factor-β-mediated Nuclear Factor-κB Activation during Breast Cancer Progression by Jason R. Neil, Maozhen Tian, William P. Schiemann

    Published in The Journal of biological chemistry (07-08-2009)
    “…The precise sequence of events that enable mammary tumorigenesis to convert transforming growth factor-β (TGF-β) from a tumor suppressor to a tumor promoter…”
    Get full text
    Journal Article
  18. 18

    X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression by Neil, Jason R, Tian, Maozhen, Schiemann, William P

    Published in The Journal of biological chemistry (07-08-2009)
    “…The precise sequence of events that enable mammary tumorigenesis to convert transforming growth factor-beta (TGF-beta) from a tumor suppressor to a tumor…”
    Get full text
    Journal Article
  19. 19

    Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-[beta] through a PGE[sub]2-dependent mechanisms by Neil, Jason R, Johnson, Kyle M, Nemenoff, Raphael A, Schiemann, William P

    Published in Carcinogenesis (New York) (01-11-2008)
    “…Although it is well established that mammary tumorigenesis converts transforming growth factor-β (TGF-β) from a tumor suppressor to a tumor promoter, the…”
    Get full text
    Journal Article
  20. 20

    Role of transforming growth factor-beta in cancer progression by Galliher, Amy J, Neil, Jason R, Schiemann, William P

    Published in Future oncology (London, England) (01-12-2006)
    “…Invasion and metastasis are the most lethal characteristics of cancer and the leading causes of cancer-related death. Transforming growth factor (TGF)-beta is…”
    Get more information
    Journal Article